Role of Efflux in Antibiotic Resistance of Achromobacter xylosoxidans and Achromobacter insuavis Isolates From Patients With Cystic Fibrosis

Role of AxyABM overexpression in acquired resistance in Achromobacter xylosoxidans

(2021) Arnaud Magallon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Hypermutator Pseudomonas aeruginosa exploits multiple genetic pathways to develop multidrug resistance during long-term infections in the airways of cystic fibrosis patients

(2020) C.A. Colque et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

LONGITUDINAL SURVEILLANCE AND COMBINATION ANTIMICROBIAL SUSCEPTIBILITY TESTING OF MULTIDRUG-RESISTANT ACHROMOBACTER SPP. FROM CYSTIC FIBROSIS PATIENTS

(2020) Ijeoma N. Okoliegbe et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Achromobacter Infections and Treatment Options

(2020) Burcu Isler et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resurrecting Old β-Lactams: Potent Inhibitory Activity of Temocillin against Multidrug-Resistant Burkholderia Species Isolates from the United States

(2019) Elise T. Zeiser et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Diversity of Achromobacter species recovered from patients with cystic fibrosis, in Argentina

(2019) Mariana Papalia et al.   REVISTA ARGENTINA DE MICROBIOLOGIA

Phage therapy against Achromobacter xylosoxidan s lung infection in a patient with cystic fibrosis: a case report

(2018) N. Hoyle et al.   RESEARCH IN MICROBIOLOGY

Replicon typing of plasmids in environmental Achromobacter sp. producing quinolone-resistant determinants

(2018) João Pedro Rueda Furlan et al.   APMIS

Acquired resistance to macrolides in Pseudomonas aeruginosa from cystic fibrosis patients

(2017) Muhammad-Hariri Mustafa et al.   EUROPEAN RESPIRATORY JOURNAL

Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study

(2017) B. D. Edwards et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Prevalence and species distribution of Achromobacter sp. cultured from cystic fibrosis patients attending the Aarhus centre in Denmark

(2017) Sinne Søberg Gade et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Immunomodulatory indications of azithromycin in respiratory disease: a concise review for the clinician

(2017) Cassondra L. Cramer et al.   POSTGRADUATE MEDICINE

High-level resistance to meropenem in clinical isolates of Pseudomonas aeruginosa in the absence of carbapenemases: role of active efflux and porin alterations

(2016) Hussein Chalhoub et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Next-Generation Epidemiology: Using Real-Time Core Genome Multilocus Sequence Typing To Support Infection Control Policy

(2016) John P. Dekker et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Impact of High Diversity of Achromobacter Populations within Cystic Fibrosis Sputum Samples on Antimicrobial Susceptibility Testing

(2016) Chloé Dupont et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Distribution of the species of Achromobacter in a French Cystic Fibrosis Centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates

(2016) Lucie Amoureux et al.   Journal of Cystic Fibrosis

Resistance to Macrolide Antibiotics in Public Health Pathogens

(2016) Corey Fyfe et al.   Cold Spring Harbor Perspectives in Medicine

Berberine Is a Novel Type Efflux Inhibitor Which Attenuates the MexXY-Mediated Aminoglycoside Resistance in Pseudomonas aeruginosa

(2016) Yuji Morita et al.   Frontiers in Microbiology

Long-Term Evolution of Burkholderia multivorans during a Chronic Cystic Fibrosis Infection Reveals Shifting Forces of Selection

(2016) Inês N. Silva et al.   mSystems

Polymyxin Susceptibility in Pseudomonas aeruginosa Linked to the MexXY-OprM Multidrug Efflux System

(2015) Keith Poole et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Core Genome Multilocus Sequence Typing Scheme for High-Resolution Typing of Enterococcus faecium

(2015) Mark de Been et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Increased Prevalence and Resistance of Important Pathogens Recovered from Respiratory Specimens of Cystic Fibrosis Patients During a Decade

(2015) Lena Raidt et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Identification and Characterization of a Serious Multidrug ResistantStenotrophomonas maltophiliaStrain in China

(2015) Yan Zhao et al.   Biomed Research International

Genomic Insights into Intrinsic and Acquired Drug Resistance Mechanisms in Achromobacter xylosoxidans

(2014) Yongfei Hu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Early treatment with inhaled antibiotics postpones next occurrence of Achromobacter in cystic fibrosis

(2013) M. Wang et al.   Journal of Cystic Fibrosis

Molecular Epidemiology of Staphylococcus epidermidis Clinical Isolates from U.S. Hospitals

(2012) Rodrigo E. Mendes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Innate Aminoglycoside Resistance of Achromobacter xylosoxidans Is Due to AxyXY-OprZ, an RND-Type Multidrug Efflux Pump

(2012) Julien Bador et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Achromobacter xylosoxidans: An Emerging Pathogen Carrying Different Elements Involved in Horizontal Genetic Transfer

(2012) German Matías Traglia et al.   CURRENT MICROBIOLOGY

Draft Genome Sequence of Pseudomonas aeruginosa Strain ATCC 27853

(2012) X. Fang et al.   JOURNAL OF BACTERIOLOGY

Rapid Detection of Extended-Spectrum- -Lactamase-Producing Enterobacteriaceae

(2012) P. Nordmann et al.   JOURNAL OF CLINICAL MICROBIOLOGY

A Multilocus Sequence Typing Scheme Implies Population Structure and Reveals Several Putative Novel Achromobacter Species

(2012) T. Spilker et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: First French data

(2012) Lucie Amoureux et al.   Journal of Cystic Fibrosis

First Description of an RND-Type Multidrug Efflux Pump in Achromobacter xylosoxidans, AxyABM

(2011) Julien Bador et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characterization of a Naturally Occurring Class D  -Lactamase from Achromobacter xylosoxidans

(2008) Y. Doi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Achromobacter xylosoxidansrespiratory tract infections in cystic fibrosis patients 

(2008) TIZIANA RASO et al.   APMIS